Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,475,394 papers from all fields of science
Search
Sign In
Create Free Account
WY 14,643
Known as:
Wy-14643
, Wyeth-14643
, WY14,643
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
pirinixic acid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
Polyunsaturated fatty acids stimulate hepatic UCP-2 expression via a PPARα-mediated pathway
M. Armstrong
,
H. Towle
2001
Corpus ID: 9281510
The discovery of homologs of the brown fat uncoupling protein(s) (UCP) UCP-2 and UCP-3 revived the hypothesis of uncoupling…
Expand
Highly Cited
2000
Highly Cited
2000
Differential effects of PPARalpha activators on induction of ectopic expression of tissue-specific fatty acid binding protein genes in the mouse liver.
K. Motojima
International Journal of Biochemistry and Cell…
2000
Corpus ID: 28418798
Highly Cited
1996
Highly Cited
1996
The effects of peroxisome proliferators on protein abundances in mouse liver.
N. Anderson
,
R. Esquer‐Blasco
,
F. Richardson
,
P. Foxworthy
,
P. Eacho
Toxicology and Applied Pharmacology
1996
Corpus ID: 19698107
We have investigated the effects of five peroxisome proliferators (PPs : clofibric acid, DEHP, WY14,643, nafenopin, and LY171883…
Expand
Highly Cited
1989
Highly Cited
1989
Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
J. Conway
,
K. Tomaszewski
,
M. J. Olson
,
R. Cattley
,
D. Marsman
,
J. Popp
Carcinogenesis
1989
Corpus ID: 23407568
Quantitative comparisons of the time course of biochemical and morphological changes induced by peroxisome proliferators…
Expand
Highly Cited
1989
Highly Cited
1989
Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
M. R. Nemali
,
M. Reddy
,
+4 authors
J. Reddy
Toxicology and Applied Pharmacology
1989
Corpus ID: 2249575
Highly Cited
1988
Highly Cited
1988
Tissue specificity and species differences in the distribution of urate oxidase in peroxisomes.
Nobuteru Usuda
,
M. Reddy
,
Takashi Hashimoto
,
Rao Ms
,
Janardan K. Reddy
Laboratory investigation; a journal of technical…
1988
Corpus ID: 36232432
The localization of urate oxidase in different tissues of rat and in the livers of selected mammalian species was investigated by…
Expand
Highly Cited
1985
Highly Cited
1985
32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
Ramesh C. Gupta
,
Sudhir K. Goel
,
K. Earley
,
Balbir Singh
,
Janardan K. Reddy
Carcinogenesis
1985
Corpus ID: 12874081
Hepatocarcinogenic peroxisome proliferators, clofibrate, ciprofibrate, Wy-14643 or di(2-ethylhexyl)phthalate, were administered…
Expand
Highly Cited
1984
Highly Cited
1984
Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella.
H. Glauert
,
J. Reddy
,
W. Kennan
,
G. Sattler
,
V. S. Rao
,
H. Pitot
Cancer Letters
1984
Corpus ID: 27649182
Highly Cited
1983
Highly Cited
1983
Peroxisome proliferation in primary cultures of rat hepatocytes.
T. Gray
,
B. Lake
,
J. Beamand
,
J. Foster
,
S. Gangolli
Toxicology and Applied Pharmacology
1983
Corpus ID: 20318055
Highly Cited
1982
Highly Cited
1982
The absence of gamma-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643.
M. Rao
,
N. Lalwani
,
D. Scarpelli
,
J. Reddy
Carcinogenesis
1982
Corpus ID: 35643274
Administration of Wy-14,643, a hypolipidemic agent which induces peroxisome proliferation, at a concentration of 0.1% (w/w) in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE